Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
0.2785
+0.0495 (21.62%)
At close: Apr 25, 2025, 4:00 PM
0.2912
+0.0127 (4.56%)
Pre-market: Apr 28, 2025, 5:48 AM EDT
Cyclacel Pharmaceuticals Revenue
In the year 2024, Cyclacel Pharmaceuticals had annual revenue of $43.00K, down -89.76%.
Revenue (ttm)
$43.00K
Revenue Growth
-89.76%
P/S Ratio
34.69
Revenue / Employee
$3,583
Employees
12
Market Cap
57.74M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
CYCC News
- 25 days ago - Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock - GlobeNewsWire
- 2 months ago - Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership - GlobeNewsWire
- 4 months ago - Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar - GlobeNewsWire
- 5 months ago - Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating Costs - GlobeNewsWire
- 5 months ago - Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds - GlobeNewsWire
- 5 months ago - Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds - GlobeNewsWire
- 5 months ago - Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update - GlobeNewsWire